ltrasound Gastric volume
- Conditions
- Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)
- Registration Number
- CTRI/2020/02/023518
- Lead Sponsor
- Hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 230
1.Age above 18yrs.
2.Patients who have consented for the procedure.
3.Patients with CKD more than or equal to Stage 3 posted for elective surgical procedures.
4.Patients with normal renal function >60ml/min/1.73m2 posted for elective surgical procedures.
1)Patient who refuse to participate or consent for the study.
2)Emergency procedures
3)Pregnancy
4)Paediatric age group
5)Preexisting known oesophageal/gastric anatomical abnormalities/post-op status.
6)Patients coming to the preoperative unit with a Ryleâ??s tube.
7)Patients taking domperidone, metoclopramide or narcotics within the specified half life of the drug and coming for surgery
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Estimated gastric volume greater than 1.5ml/kg body weight or patients with particulate or solid content.Timepoint: Prior to premedication and induction of anaesthesia.
- Secondary Outcome Measures
Name Time Method Delay in oral intake postoperatively.Timepoint: Postoperative period from immediate postoperatively upto 24 hours postoperatively, the time to first oral intake will be recorded and if any delays, the cause for delay will also be recorded.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.